From fat-loss fad to preventative medicine for a range of chronic health conditions that result from obesity and other metabolic conditions.

Over the last couple of weeks, I have received multiple requests for comment on a small speculative radiology software stock called 4D Medical (ASX: 4DX), in part because it announced on July 31, 2025 ...

A spate of recent Australian cases where AI use by lawyers has created false case citations heralds a new era of legal issues for courts.

Lovisa Holdings Ltd (ASX: LOV) delivered another year of strong global growth in FY 2025, setting the stage for further expansion as a key competitor struggles. Backed by retail doyen and chairman ...

I’ve written about IPD Group (ASX: IPG) several times over the last few months, both here on A Rich Life, and on Livewire Markets. I purchased shares in IPD Group between February and April of this ...

Why homelessness advocacy group Everybody's Home argues it makes sense, citing hundreds of millions in currently foregone tax revenue.

How to spot future large cap shares among ASX small caps. We cover key signals, a case study – PME vs NXT – and a potential ...

Vysarn shareholders will be looking for success in their nascent water division after solid but unexceptional FY 2025 results.

The RPM Global share price is now up about 40% since the FY 2025 results and over 200% since I originally made ASX: RUL a buy recommendation ...

When I wrote about LaserBond (ASX:LBL) on July 14th for A Rich Life here, the share price was around 37 cents. At that time, I asked whether the market was undervaluing the business. I also pointed ...